Stress ulcer prophylaxis plus enteral nutrition versus enteral nutrition alone in critically ill patients at risk for gastrointestinal bleeding: a propensity-matched analysis

2020 ◽  
Vol 46 (10) ◽  
pp. 1948-1949
Author(s):  
Hiroyuki Ohbe ◽  
Kojiro Morita ◽  
Hiroki Matsui ◽  
Kiyohide Fushimi ◽  
Hideo Yasunaga
2018 ◽  
Vol 43 ◽  
pp. 108-113 ◽  
Author(s):  
Karim El-Kersh ◽  
Bilal Jalil ◽  
Stephen A. McClave ◽  
Rodrigo Cavallazzi ◽  
Juan Guardiola ◽  
...  

2021 ◽  
Vol 50 (1) ◽  
pp. 288-288
Author(s):  
Majid Chammas ◽  
Saskya Byerly ◽  
Jennifer Lynde ◽  
Gerd Pust ◽  
Rishi Rattan ◽  
...  

2003 ◽  
Vol 29 (8) ◽  
pp. 1306-1313 ◽  
Author(s):  
Christophe Faisy ◽  
Emmanuel Guerot ◽  
Jean-Luc Diehl ◽  
Eléonore Iftimovici ◽  
Jean-Yves Fagon

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Myung Jin Song ◽  
Seok Kim ◽  
Dachung Boo ◽  
Changhyun Park ◽  
Sooyoung Yoo ◽  
...  

AbstractProton pump inhibitors (PPIs), followed by histamine 2 receptor antagonists (H2RAs), are the most commonly used drugs to prevent gastrointestinal bleeding in critically ill patients through stress ulcer prophylaxis. The relative efficacy and drug-related adverse events of PPIs and H2RAs remain unclear. In this retrospective, observational, comparative cohort study, PPIs and H2RAs for stress ulcer prophylaxis in critically ill patients were compared using a common data model. After propensity matching, 935 patients from each treatment group (PPI or H2RA) were selected. The PPI group had a significantly higher 90-day mortality than the H2RA group (relative risk: 1.28; P = 0.01). However, no significant inter-group differences in the risk of clinically important gastrointestinal bleeding were observed. Moreover, there were no significant differences between the groups concerning the risk of pneumonia or Clostridioides difficile infection, which are known potential adverse events related to these drugs. Subgroup analysis of patients with high disease severity were consistent with those of the total propensity score-matched population. These findings do not support the current recommendations, which prefer PPIs for gastrointestinal bleeding prophylaxis in the intensive care unit.


Author(s):  
William Faisal ◽  
Luciana Rotty

Critically ill patients are at risk for stress ulcers in the upper digestive tract. Various risk factors have been associated with this condition. Patients who are critically ill are at risk of bleeding due to stress related mucosal disease (SRMD). Upper gastrointestinal tract problems usually occur as a result of severe physiological stress. Patients may develop gastric erosion and develop stress ulcers with severe gastrointestinal bleeding which can be fatal. Routine pharmacological use of stress ulcer prophylaxis (SUP) does not reduce overall mortality in intensive care patients. This increases the risk of infectious complications, particularly nosocomial pneumonia and Clostridium difficile-associated diarrhea. Early enteral nutrition has been shown to be effective in preventing stress ulceration of the upper gastrointestinal tract in critically ill patients. Routine use of stress ulcer prophylaxis in all critically ill patients may be dangerous and does not appear to be cost-effective. SUP administration must follow an algorithm that clearly balances risks and benefits.


CHEST Journal ◽  
2017 ◽  
Vol 152 (4) ◽  
pp. A345
Author(s):  
Diwas Shahi ◽  
Ajai Rajabalan ◽  
Jonathan Barrera-Calix ◽  
Sunil Paudel ◽  
Tamer Said Ahmed ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document